| ARDEX | DODGX | ARDEX / DODGX | |
| Total Expense Ratio | 0.97 | 0.51 | 190% |
| Annual Report Gross Expense Ratio | 1.10 | 0.51 | 216% |
| Fund Existence | 20 years | 61 years | - |
| Gain YTD | 7.598 | 12.037 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 2500 | 80% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 67.4M | 119B | 0% |
| Annual Yield % from dividends | 3.37 | 1.32 | 255% |
| Returns for 1 year | -39.70 | 3.03 | -1,312% |
| Returns for 3 years | -37.29 | 29.74 | -125% |
| Returns for 5 years | -37.46 | 50.51 | -74% |
| Returns for 10 years | -34.21 | 83.18 | -41% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VBK | 312.79 | 3.75 | +1.21% |
| Vanguard Small-Cap Growth ETF | |||
| DEUS | 59.15 | 0.62 | +1.06% |
| Xtrackers Russell US Multifactor ETF | |||
| IHE | 84.11 | 0.71 | +0.85% |
| iShares US Pharmaceuticals ETF | |||
| OCTM | 32.58 | 0.02 | +0.05% |
| FT Vest U.S. Equity Max Buffer ETF – Oct | |||
| SCDL | 37.75 | N/A | N/A |
| ETRACS 2x Leveraged US Div Fctr TR ETN | |||